“…National Pharmacovigilance Program was launched in India in 2004 and restarted in 2010 as Pharmacovigilance Program of India (PvPI) under Ministry of Health and Family Welfare, Government of India, to monitor the safety of medicines in Indian population. 3,4 Indian Pharmacopoeia Commission is the National Coordination Centre (NCC) which collects the ADR reports and further recommends to Central Drugs Standard Control Organization (CDSCO) and Uppsala Monitoring Center (UMC) for regulatory actions. 5 ADR reporting in India is still below 1% compared to 5% global reporting.…”